Whole Lung Lavage

  • Jean S. BussièresEmail author
  • Etienne J. Couture


Patients with pulmonary alveolar proteinosis have a restrictive disease and are hypoxic. Lavage of one lung with large quantities of saline requires careful lung isolation. For more than 10 years, bilateral lung lavage has been performed during the same anesthetic period. GM-CSF-associated therapy is now a complementary treatment to WLL for pulmonary alveolar proteinosis, when needed.


Lavage Lung Resection Pulmonary function Pap Alveolar 


  1. 1.
    Vincente G. Le lavage des poumons. Presse Med. 28:1266–8.Google Scholar
  2. 2.
    Ramirez-Riviera J. The strange beginnings of diagnostic and therapeutic bronchoalveolar lavage. PRHS. 1992;11(1):27.Google Scholar
  3. 3.
    Ramirez-Riviera J, Kieffer RF, Ball WC Jr. Bronchopulmonary lavage in man. Ann Intern Med. 1965;63(5):819–28.CrossRefGoogle Scholar
  4. 4.
    Ramirez J. Bronchopulmonary lavage. New techniques and observations. Dis Chest. 1966;50(6):581–8.CrossRefGoogle Scholar
  5. 5.
    Ramirez-Riviera J, Schultz RB, Dutton RE. Pulmonary alveolar proteinosis: a new technique and rationale for treatment. Arch Intern Med. 1963;112:419–31.CrossRefGoogle Scholar
  6. 6.
    Spragg RG, Benumof JL, Alfery DD. New methods for the performance of unilateral lung lavage. Anesthesiology. 1982;57(6):535–8.CrossRefGoogle Scholar
  7. 7.
    Bussieres JS. Whole lung lavage. Anesthesiol Clin North Am. 2001;19(3):543–58.CrossRefGoogle Scholar
  8. 8.
    Wilt JL, Banks DE, Weissman DN, Parker JE, Vallyathan V, Castranova V, et al. Reduction of lung dust burden in pneumoconiosis by whole-lung lavage. J Occup Environ Med. 1996;38(6):619–24.CrossRefGoogle Scholar
  9. 9.
    Venkateshiah SB, Yan TD, Bonfield TL, Thomassen MJ, Meziane M, Czich C, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest. 2006;130(1):227–37.CrossRefGoogle Scholar
  10. 10.
    Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med. 2003;349(26):2527–39.CrossRefGoogle Scholar
  11. 11.
    Huizar I, Kavuru MS. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management. Curr Opin Pulm Med. 2009;15(5):491–8.CrossRefGoogle Scholar
  12. 12.
    Lee K, Levin D, Webb W, Chen D, Storto M, Golden J. Pulmonary alveolar proteinosis: high-resolution CT, chest radiographic, and functional correlations. Chest. 1997;111:989–95.CrossRefGoogle Scholar
  13. 13.
    Arcasoy SM, Lanken PN. Images in clinical medicine. Pulmonary alveolar proteinosis. N Engl J Med. 2002;347(26):2133.CrossRefGoogle Scholar
  14. 14.
    Wong CA, Wilsher ML. Treatment of exogenous lipoid pneumonia by whole lung lavage. Aust NZ J Med. 1994;24(6):734–5.CrossRefGoogle Scholar
  15. 15.
    Martin RJ, Rogers RM, Myers NM. PUlmonary alveolar proteinosis: shunt fraction and lactic acid dehydrogenase concentration as aids to diagnosis. Am Rev Respir Dis. 1978;117(6):1059–62.PubMedGoogle Scholar
  16. 16.
    Costello JF, Moriarty DC, Branthwaite MA, Turner-Warwick M, Corrin B. Diagnosis and management of alveolar proteinosis: the role of electron microscopy. Thorax. 1975;30(2):121–32.CrossRefGoogle Scholar
  17. 17.
    Gilmore LB, Talley FA, Hook GE. Classification and morphometric quantitation of insoluble materials from the lungs of patients with alveolar proteinosis. Am J Pathol. 1988;133(2):252–64.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002;166(2):215–35.CrossRefGoogle Scholar
  19. 19.
    Goldstein LS, Kavuru MS, Curtis-McCarthy P, Christie HA, Farver C, Stoller JK. Pulmonary alveolar proteinosis: clinical features and outcomes. Chest. 1998;114(5):1357–62.CrossRefGoogle Scholar
  20. 20.
    Rubinstein I, Mullen JB, Hoffstein V. Morphologic diagnosis of idiopathic pulmonary alveolar lipoproteinosis-revisited. Arch Intern Med. 1988;148(4):813–6.CrossRefGoogle Scholar
  21. 21.
    Bonfield TL, Kavuru MS, Thomassen MJ. Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol. 2002;105(3):342–50.CrossRefGoogle Scholar
  22. 22.
    Lin FC, Chang GD, Chern MS, Chen YC, Chang SC. Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis. Thorax. 2006;61(6):528–34.CrossRefGoogle Scholar
  23. 23.
    Kavuru MS, Popovich M. Therapeutic whole lung lavage: a stop-gap therapy for alveolar proteinosis. Chest. 2002;122(4):1123–4.CrossRefGoogle Scholar
  24. 24.
    Borie R, Debray MP, Laine C, Aubier M, Crestani B. Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J. 2009;33(6):1503–6.CrossRefGoogle Scholar
  25. 25.
    Luisetti M, Rodi G, Perotti C, Campo I, Mariani F, Pozzi E, et al. Plasmapheresis for treatment of pulmonary alveolar proteinosis. Eur Respir J. 2009;33(5):1220–2.CrossRefGoogle Scholar
  26. 26.
    Garber B, Albores J, Wang T, Neville TH. A plasmapheresis protocol for refractory pulmonary alveolar proteinosis. Lung. 2015;193(2):209–11.CrossRefGoogle Scholar
  27. 27.
    Parker LA, Novotny D. Recurrent alveolar proteinosis following double lung transplantation. Chest. 1997;111:1457.CrossRefGoogle Scholar
  28. 28.
    Loubser PG. Validity of pulmonary artery catheter-derived hemodynamic information during bronchopulmonary lavage. J Cardiothorac Vasc Anesth. 1997;11(7):885–8.CrossRefGoogle Scholar
  29. 29.
    Cohen E, Eisenkraft JB. Bronchopulmonary lavage: effects on oxygenation and hemodynamics. J Cardiothorac Anesth. 1990;4(5):609–15.CrossRefGoogle Scholar
  30. 30.
    McMahon CC, Irvine T, Conacher ID. Transoesophageal echocardiography in the management of whole lung lavage. Br J Anaesth. 1998;81(2):262–4.CrossRefGoogle Scholar
  31. 31.
    Swenson JD, Astle KL, Bailey PL. Reduction in left ventricular filling during bronchopulmonary lavage demonstrated by transesophageal echocardiography. Anesth Analg. 1995;81(3):634–7.PubMedGoogle Scholar
  32. 32.
    Bardoczky GI, Engelman E, d'Hollander A. Continuous spirometry: an aid to monitoring ventilation during operation. Br J Anaesth. 1993;71(5):747–51.CrossRefGoogle Scholar
  33. 33.
    Hammon WE, McCaffree DR, Cucchiara AJ. A comparison of manual to mechanical chest percussion for clearance of alveolar material in patients with pulmonary alveolar proteinosis (phospholipidosis). Chest. 1993;103(5):1409–12.CrossRefGoogle Scholar
  34. 34.
    Bracci L. Role of physical therapy in management of pulmonary alveolar proteinosis. A case report. Phys Ther. 1988;68(5):686–9.CrossRefGoogle Scholar
  35. 35.
    Bingisser R, Kaplan V, Zollinger A, Russi EW. Whole-lung lavage in alveolar proteinosis by a modified lavage technique. Chest. 1998;113(6):1718–9.CrossRefGoogle Scholar
  36. 36.
    Nadeau MJ, Cote D, Bussieres JS. The combination of inhaled nitric oxide and pulmonary artery balloon inflation improves oxygenation during whole-lung lavage. Anesth Analg. 2004;99(3):676–9. table of contents.CrossRefGoogle Scholar
  37. 37.
    Julien T, Caudine M, Barlet H, Wintrebert P, Aubas P, du Cailar J. Effect of positive end expiratory pressure on arterial oxygenation during bronchoalveolar lavage for proteinosis. Annales francaises d’anesthesie et de reanimation. 1986;5(2):173–6.CrossRefGoogle Scholar
  38. 38.
    Moutafis M, Dalibon N, Colchen A, Fischler M. Improving oxygenation during bronchopulmonary lavage using nitric oxide inhalation and almitrine infusion. Anesth Analg. 1999;89(2):302–4.PubMedGoogle Scholar
  39. 39.
    Biervliet J, Peper J, Roos C, et al. Whole-lung lavage under hyperbaric conditions. In: Erdmann W, editor. Oxygen transport to tissue XIV. NewYork: Plenum Press; 1992.Google Scholar
  40. 40.
    Vymazal T, Krecmerova M. Respiratory strategies and airway management in patients with pulmonary alveolar proteinosis: a review. Biomed Res Int. 2015;2015:639543.CrossRefGoogle Scholar
  41. 41.
    Cohen ES, Elpern E, Silver MR. Pulmonary alveolar proteinosis causing severe hypoxemic respiratory failure treated with sequential whole-lung lavage utilizing venovenous extracorporeal membrane oxygenation: a case report and review. Chest. 2001;120(3):1024–6.CrossRefGoogle Scholar
  42. 42.
    Chauhan S, Sharma KP, Bisoi AK, Pangeni R, Madan K, Chauhan YS. Management of pulmonary alveolar proteinosis with whole lung lavage using extracorporeal membrane oxygenation support in a postrenal transplant patient with graft failure. Ann Card Anaesth. 2016;19(2):379–82.CrossRefGoogle Scholar
  43. 43.
    Hasan N, Bagga S, Monteagudo J, Hirose H, Cavarocchi NC, Hehn BT, et al. Extracorporeal membrane oxygenation to support whole-lung lavage in pulmonary alveolar proteinosis: salvage of the drowned lungs. J Bronchology Interv Pulmonol. 2013;20(1):41–4.CrossRefGoogle Scholar
  44. 44.
    Zhou B, Zhou HY, Xu PH, Wang HM, Lin XM, Wang XD. Hyperoxygenated solution for improved oxygen supply in patients undergoing lung lavage for pulmonary alveolar proteinosis. Chin Med J. 2009;122(15):1780–3.PubMedGoogle Scholar
  45. 45.
    Ciravegna B, Sacco O, Moroni C, Silvestri M, Pallecchi A, Loy A, et al. Mineral oil lipoid pneumonia in a child with anoxic encephalopathy: treatment by whole lung lavage. Pediatr Pulmonol. 1997;23(3):233–7.CrossRefGoogle Scholar
  46. 46.
    McKenzie B, Wood RE, Bailey A. Airway management for unilateral lung lavage in children. Anesthesiology. 1989;70(3):550–3.CrossRefGoogle Scholar
  47. 47.
    Paquet C, Karsli C. Technique of lung isolation for whole lung lavage in a child with pulmonary alveolar proteinosis. Anesthesiology. 2009;110(1):190–2.CrossRefGoogle Scholar
  48. 48.
    Moazam F, Schmidt JH, Chesrown SE, Graves SA, Sauder RA, Drummond J, et al. Total lung lavage for pulmonary alveolar proteinosis in an infant without the use of cardiopulmonary bypass. J Pediatr Surg. 1985;20(4):398–401.CrossRefGoogle Scholar
  49. 49.
    Hiratzka LF, Swan DM, Rose EF, Ahrens RC. Bilateral simultaneous lung lavage utilizing membrane oxygenator for pulmonary alveolar proteinosis in an 8-month-old infant. Ann Thorac Surg. 1983;35(3):313–7.CrossRefGoogle Scholar
  50. 50.
    Lippmann M, Mok MS, Wasserman K. Anaesthetic management for children with alveolar proteinosis using extracorporeal circulation. Report of two cases. Br J Anaesth. 1977;49(2):173–7.CrossRefGoogle Scholar
  51. 51.
    Tsai WC, Lewis D, Nasr SZ, Hirschl RB. Liquid ventilation in an infant with pulmonary alveolar proteinosis. Pediatr Pulmonol. 1998;26(4):283–6.CrossRefGoogle Scholar
  52. 52.
    Libbey J. Anesthésie-Réanimation en Chirurgie Thoracique. In: Bussières JS, Léone M. Anesthésie-Réanimation en Chirurgie Thoracique. Paris: Arnette-Collection verte, John Libbey; 2017Google Scholar
  53. 53.
    Slinger PD. Principles and practice of anesthesia for thoracic surgery. 1st ed. New York/London: Springer; 2011.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of AnesthesiologyInstitut Universitaire de Cardiologie et de Pneumologie de Québec – Université LavalQuebéc CityCanada
  2. 2.Department of Medicine, Critical Care DivisionUniversity of MontrealMontrealCanada

Personalised recommendations